GNLKQ (Genelink) Total Liabilities: $4.49 Mil (As of Sep. 2013)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Genelink Total Liabilities?

Genelink GNLKQ Total Liabilities is $4.49 Mil as of Sep. 2013.

Genelink's Total Liabilities for the quarter that ended in Sep. 2013 was $4.49 Mil.

Genelink's quarterly Total Liabilities increased from Mar. 2013 ($4.25 Mil) to Jun. 2013 ($4.37 Mil) and increased from Jun. 2013 ($4.37 Mil) to Sep. 2013 ($4.49 Mil).

Genelink's annual Total Liabilities increased from Dec. 2010 ($2.51 Mil) to Dec. 2011 ($4.26 Mil) but then declined from Dec. 2011 ($4.26 Mil) to Dec. 2012 ($4.12 Mil).

Genelink Total Liabilities Historical Data

* Premium members only.

The historical data trend for Genelink's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genelink Total Liabilities Chart

Genelink Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.49 2.62 2.51 4.26 4.12

Genelink Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.60 4.12 4.25 4.37 4.49

Genelink Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genelink's Total Liabilities for the fiscal year that ended in Dec. 2012 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.839+(0+1.814
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.463+0+0)
=4.12

Total Liabilities=Total Assets (A: Dec. 2012 )-Total Equity (A: Dec. 2012 )
=1.455--2.661
=4.12

Genelink's Total Liabilities for the quarter that ended in Sep. 2013 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.243+(1.191+0.704
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.35+0+0)
=4.49

Total Liabilities=Total Assets (Q: Sep. 2013 )-Total Equity (Q: Sep. 2013 )
=1.284--3.203
=4.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $4.49 Mil mean?
Genelink (GNLKQ) has a Total Liabilities of $4.49 Mil as of Sep. 2013. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Genelink and its competitors.
Is Genelink's Total Liabilities too high?
Genelink's current Total Liabilities is $4.49 Mil.
How does Genelink's Total Liabilities compare to VITIF and HSTC?
Genelink's Total Liabilities of $4.49 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Genelink and its competitors. Genelink's current Total Liabilities is $4.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genelink stock overvalued right now?
Genelink (GNLKQ) has a current Total Liabilities of $4.49 Mil. The current Total Liabilities is $4.49 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Genelink (GNLKQ), the current Total Liabilities is $4.49 Mil as of Sep. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genelink Business Description

Address 8250 Exchange Drive, Suite 120, Orlando, FL, USA, 32809
Genelink Inc is a genetics-based, personal healthcare firm that has developed DNA assessments measuring personal DNA tendencies. These small differences in DNA, called SNPs can indicate genetic variants, the protein products of which may not be performing at optimal levels and can be linked to aging and other wellness issues. The company's scientists use the DNA assessments information from each client to formulate products to optimize health and wellness within normal ranges. The company has a compilation of issued and pending patents that center on using DNA analysis for the purpose of customizing nutrition and skin care formulations for wellness and anti-aging.